发育中的耳囊中SOX9和Wnt的拮抗活性确保SOX10对内淋巴发育的控制
Opposing activity of SOX9 and Wnt in the developing otocyst ensures SOX10 control of endolymphatic development.
文献信息
| PMID | 42832658 |
|---|---|
| 原文 | 在 PubMed 查看原文 ↗ |
| 发表日期 | 2026 |
| 作者 | Ka Chi Chu |
| 作者单位 | School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. |
| 期刊 | Proceedings of the National Academy of Sciences of the United States of America |
| SCI 分区 | Q1 |
| IF | 10.6 |
| 研究类型 | 基础研究 · 基础/转化 |
| 所属专科 | 耳科 |
中文摘要
背景: 内耳的正常发育,包括内淋巴囊祖细胞的指定和分化,对听力和平衡至关重要。在导致躯干发育异常和耳聋的SOX9Y440X/+突变小鼠模型中,妊娠中期内淋巴系统发育受损与SOX10下调相关。其潜在的分子原因和意义尚不清楚。方法:在这里,我们在Sox9Y440X/+小鼠中发现,Sox10表达在明显分化之前,在E10.5耳囊的背内侧区域(通常发育为内淋巴管和囊)下调。E10.5耳囊的单细胞转录组分析显示Wnt通路基因表达增加,这与Sox10表达的区域特异性降低相关。通过在早期耳囊和更发育的内耳中表达稳定β-连环蛋白强制升高Wnt信号,抑制了Sox10表达。Wnt在源自人类多能干细胞的耳囊样类器官中对SOX10表达产生抑制作用。体外反式激活实验揭示了SOX9和Wnt信号对由保守增强子介导的Sox10反式激活的拮抗作用,这些增强子具有相邻/重叠的SOX9和TCF/LEF结合(Wnt效应子)基序。结果:我们提出一种保守的SOX9-Wnt拮抗作用,通过保守增强子调节SOX10以调控内淋巴细胞命运。结论:SOX9Y440X/+突变通过显性负效应和单倍剂量不足效应破坏这一调控回路,最终导致耳囊中祖细胞建立受损,而这些祖细胞对于听力和平衡的内淋巴系统发育至关重要。
英文摘要
Proper development of the inner ear, including specification and differentiation of progenitors for the endolymphatic sac, is crucial for hearing and balance. In a mouse model of the SOX9Y440X/+ mutation that causes campomelic dysplasia and deafness, impaired development of the endolymphatic system at mid-gestation was associated with SOX10 downregulation. The underlying molecular causes and significance are unclear. Here, we found in Sox9Y440X/+ mice, Sox10 expression was downregulated, prior to overt differentiation, in the dorsomedial aspect of the E10.5 otic vesicle that normally becomes the endolymphatic duct and sac. Single-cell transcriptomic profiling of E10.5 otic vesicles showed increased expression of Wnt pathway genes that was associated with the domain-specific decrease in Sox10 expression. Forced elevation of Wnt signaling by expression of stabilized β-catenin in the early otocyst and more developed inner ears, suppressed Sox10 expression. Wnt exerted an inhibitory effect on SOX10 expression in otocyst-like organoids derived from human pluripotent stem cells. In vitro transactivation assays reveal antagonistic action of SOX9 and Wnt signaling on Sox10 transactivation mediated by conserved enhancers with neighboring/overlapping SOX9- and TCF/LEF-binding (Wnt effectors) motifs. We propose a conserved SOX9-Wnt antagonism acting via conserved enhancers, regulates SOX10 to modulate endolymphatic cell fate. The SOX9Y440X/+ mutation disrupts this regulatory circuit through both dominant-negative and haploinsufficient effects culminating in impaired establishment of progenitors in the otocyst that are essential for the development of the endolymphatic system for hearing and balance.